India clears Neotame for use in drugs
Neotame, a recently introduced high intensity sweetener developed by US company NutraSweet, has been approved by the health authorities in India for use in pharmaceutical preparations.
Neotame, a recently introduced high intensity sweetener developed by US company NutraSweet, has been approved by the health authorities in India for use in pharmaceutical preparations.
Vectura, a UK biotechnology company which is developing an inhaled alternative to orally acting impotence drugs such as Pfizer's Viagra (sildenafil), has announced plans to float on the London stock market.
Scientists in the UK are tipped to be given approval this week to create cloned human embryos to harvest stem cells to treat diabetes patients and with the possibility of treating other diseases such as Parkinson's and Alzheimer's.
UK company Laminar Medica has launched a new shipping container for pharmaceuticals that according to tests does not deviate from the set temperature range, even after 450 intercontinental transportations.
Swiss active pharmaceutical ingredients (API) company Siegfried believes it has found a shortcut on the path to market for generic drugs in the European Union, allowing it to launch drugs immediately after their patents expire.